Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin‐intolerant asthmatics
- 27 February 2013
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 18 (4) , 711-717
Abstract
Background and objective: Anomalies in the regulation of cyclooxygenase (COX)‐1 and ‐2 have been described in nasal polyps of aspirin‐induced asthma (AIA). Whether these anomalies are specific to nasal polyps or affect all the nasal mucosa (NM) of upper airways is still unclear. The objective of this study was to compare the COX pathway in NM of AIA patients with the NM of control subjects.Methods: Fibroblasts were isolated from NM of five AIA patients (AIA‐NM) and five control subjects (control‐NM). Cells were treated with 10 ng/mL interleukin (IL)‐1β for up to 72 h. Prostaglandin E2 (PGE2) production was measured by enzyme‐linked immunosorbent assay (ELISA), expression of COX‐1 protein by Western blot and COX‐2 protein by ELISA, Western blot and immunofluorescence techniques.Results: IL‐1β increased PGE2 production and COX‐1 protein expression in control‐NM fibroblasts, but no changes were found in AIA‐NM. IL‐1β provoked a significant time‐dependent increase in COX‐2 protein expression in control‐NM fibroblasts but had a very mild effect on COX‐2 protein expression in AIA‐NM.Conclusions: Our data suggest that abnormalities in the COX pathway are not a phenomenon exclusive to nasal‐polyp mucosa as they are also present in all the NM of AIA patients. These anomalies may be involved in the pathogenesis of airway inflammation and non‐steroidal anti‐inflammatory drug intolerance in asthma patients with chronic rhinosinusitis and nasal polyposis.Keywords
This publication has 26 references indexed in Scilit:
- Old and new generation lipid mediators in acute inflammation and resolutionProgress in Lipid Research, 2011
- Clinical and pathologic perspectives on aspirin sensitivity and asthmaJournal of Allergy and Clinical Immunology, 2006
- Expression of 5‐lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin‐intolerant asthmaThe Journal of Pathology, 2006
- Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposisJournal of Allergy and Clinical Immunology, 2005
- Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and InhibitionPharmacological Reviews, 2004
- Differential Metabolism of Arachidonic Acid in Nasal Polyp Epithelial Cells Cultured from Aspirin-sensitive and Aspirin-tolerant PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Cyclooxygenase-2 mRNA Is Downexpressed in Nasal Polyps from Aspirin-sensitive AsthmaticsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.Journal of Clinical Investigation, 1998
- Urinary Excretion of Leukotriene E4 and 11-dehydro-Thromboxane B2 in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in AsthmaticsAmerican Review of Respiratory Disease, 1992
- Release of Peptide Leukotriene into Nasal Secretions after Local Instillation of Aspirin in Aspirin-sensitive Asthmatic PatientsAmerican Review of Respiratory Disease, 1992